MiR-30a attenuates osteoclastogenesis via targeting DC-STAMP-c-Fos-NFATc1 signaling

MiR-30a 通过靶向 DC-STAMP-c-Fos-NFATc1 信号减弱破骨细胞生成

阅读:10
作者:Yiran Yin, Lian Tang, Jieying Chen, Xiaobo Lu

Abstract

Osteoclast is a kind of unique cells which is responsible for bone matrix absorption. It was widely reported that microRNAs (miRNAs) could regulate several physiological processes, including osteoclastogenesis. In our study, microarray analysis showed that miR-30a was down-regulated during osteoclastogenesis after RANKL (receptor activator of nuclear factor κB ligand) stimulation. Osteoclasts and actin-ring formation as well as bone resorption were inhibited when miR-30a was overexpressed in osteoclast precursor cells. Meantime, when miR-30a was inhibited in osteoclast precursor cells, osteoclasts and actin-ring formation as well as bone resorption were promoted. Furthermore, we discovered that miR-30a overexpression inhibited the protein levels of DC-STAMP, c-Fos and NFATc1. However, when DC-STAMP was inhibited by using a DC-STAMP siRNA, we could not detect the inhibition effect of osteoclastogenesis and bone resorption induced by miR-30a. In conclusion, miR-30a attenuated osteoclastogenesis via suppression of DC-STAMP-c-Fos-NFATc1 signaling pathway. On these grounds, this study may reveal a new promising target for the treatment of osteoporosis and other osteopenic disorders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。